India ECM 2020 Mid-Year Review - A Year of Secondary and Rights Issues
Its been a quiet year for listings for most of Asia-Pacific with only Hong Kong being a more recent exception. To say that its been a quite year...
431 Views
SK Biopharm IPO Industry Analysis & Contract Details
In this insight, we provide further details on the SK Biopharmaceuticals (BIO SK) IPO, including the industry and competitive analysis. We have...
218 Views
ECM Weekly (10 May 2020) - Kingsoft Cloud, NetEase, Central China New Life, Peijia Medical, Kintor,
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. As...
304 Views
Hindustan Unilever Placement - As Expected, Doing It Right
In my insight earlier this week, Hindustan Unilever Prospective Placement - Early Look - The US$3.6bn Overhang, I wrote about how GlaxoSmithKline...
407 Views
Hindustan Unilever Prospective Placement - Early Look - The US$3.6bn Overhang
GlaxoSmithKline PLC (GSK LN) owns about 5.7% of Hindustan Unilever (HUVR IN), through shares that it recently received upon the completion of...
394 Views